Skip to content
value.today

electroCore, Inc. vs Harvard Bioscience, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • electroCore, Inc. is the larger company by market value: $75 M against $38 M for Harvard Bioscience, Inc., 2.0 times as much (market caps of Oct 30, 2026 for electroCore, Inc. and Oct 26, 2026 for Harvard Bioscience, Inc.).
  • Harvard Bioscience, Inc. had more revenue: $87 M against $32 M for electroCore, Inc., both in the year to December 2025.
  • Both made a net loss: $14 M for electroCore, Inc. and $57 M for Harvard Bioscience, Inc.
  • electroCore, Inc. keeps more of each dollar of sales: a net margin of -43.6% against -65.5% for Harvard Bioscience, Inc.
  • electroCore, Inc.'s revenue grew faster in its latest fiscal year: +27.2% against -8.1% for Harvard Bioscience, Inc.
  • Both are in the distress zone of the Altman Z-score.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0581151732312020202120222023202420252026electroCore, Inc. 166Harvard Bioscience, Inc. 32

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025electroCore, Inc. $0BHarvard Bioscience, Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureelectroCore, Inc.
ECOR · #19,820 in the world
Harvard Bioscience, Inc.
HBIO · #22,291 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryMedical InstrumentsMedical Instruments
Founded—1901
Size
Market cap$75 M$38 M
Revenue$32 M$87 M
Net income$-14 M▲ best$-57 M
Employees83—
Valuation
Price to sales2.0×0.4×
Price to book—2.7×
Free cash flow yield-11.0%14.5%▲ best
Profitability
Gross margin86.8%▲ best57.7%
Operating margin-41.1%▲ best-56.1%
Net margin-43.6%▲ best-65.5%
Return on equity—-147.1%
Growth
Revenue growth27.2%▲ best-8.1%
Revenue growth, 3 years a year55.1%▲ best-8.6%
Financial strength
Debt to equity—2.6×
Interest cover—-37.4×
Cash
Free cash flow margin-25.8%6.3%▲ best
Strength scores
Piotroski F-score—5 of 9
Altman Z-score zonedistressdistress
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, electroCore, Inc. or Harvard Bioscience, Inc.?

electroCore, Inc. is the larger company by market value: $75 M against $38 M for Harvard Bioscience, Inc., 2.0 times as much (market caps of Oct 30, 2026 for electroCore, Inc. and Oct 26, 2026 for Harvard Bioscience, Inc.).

Which makes more money, electroCore, Inc. or Harvard Bioscience, Inc.?

Harvard Bioscience, Inc. had more revenue: $87 M against $32 M for electroCore, Inc., both in the year to December 2025. Both made a net loss: $14 M for electroCore, Inc. and $57 M for Harvard Bioscience, Inc.

Which is more profitable, electroCore, Inc. or Harvard Bioscience, Inc.?

electroCore, Inc. keeps more of each dollar of sales: a net margin of -43.6% against -65.5% for Harvard Bioscience, Inc.

Which is growing faster, electroCore, Inc. or Harvard Bioscience, Inc.?

electroCore, Inc.'s revenue grew faster in its latest fiscal year: +27.2% against -8.1% for Harvard Bioscience, Inc.

Which is financially stronger, electroCore, Inc. or Harvard Bioscience, Inc.?

Both are in the distress zone of the Altman Z-score.

Sources#

Every figure on this page comes from these, with the date shown next to it.